Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Accuhale LLC v. AstraZeneca LP et al
Case Number:
6:11-cv-00707
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 07, 2013
AstraZeneca Can't Duck Patent Claim Over Symbicort Inhaler
A Texas federal judge ruled Tuesday that Accuhale LLC's suit alleging AstraZeneca LP infringed a patent for a pressurized metered-dose inhaler indicator could move forward, saying AstraZeneca hadn't proven that the patent was indefinite and invalid.
-
January 03, 2012
AstraZeneca's Symbicort Inhaler Triggers Patent Suit
Texas-based Accuhale LLC hit AstraZeneca PLC with a patent infringement suit Thursday, claiming the pharmaceutical giant violated federal law with its Symbicort pressurized metered-dose inhaler for the management of asthma and chronic obstructive pulmonary disease.